13 employees
Cilian AG is a biotechnology company developing and marketing a novel protein expression system based on ciliates.
2001
$6.2M
from 2 investors over 2 rounds
Cilian AG raised undisclosed on October 22, 2009
Investors: Lonza
Cilian AG raised $6.2M on April 2, 2004
Investors: ABN AMRO Energy Transition Fund